InterCure Ltd. (TLV:INCR)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
419.80
-2.40 (-0.57%)
At close: Dec 4, 2025
-15.31%
Market Cap 229.55M
Revenue (ttm) 243.12M
Net Income (ttm) -70.93M
Shares Out 54.68M
EPS (ttm) -1.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,773
Average Volume 59,324
Open 422.20
Previous Close 422.20
Day's Range 419.00 - 424.90
52-Week Range 418.40 - 670.00
Beta 0.58
RSI 32.77
Earnings Date Dec 1, 2025

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 ... [Read more]

Sector Healthcare
Founded 1994
Employees 320
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol INCR
Full Company Profile

Financial Performance

In 2024, InterCure's revenue was 238.85 million, a decrease of -32.82% compared to the previous year's 355.55 million. Losses were -67.80 million, 9.42% more than in 2023.

Financial Statements

News

There is no news available yet.